394 related articles for article (PubMed ID: 27141897)
1. [Analysis of correlation between pulmonary function and expression levels of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinase-1 among toluene diisocyanate exposed workers].
Miao PP; Meng T; Jia Q; Niu Y; Ye M; Ji YQ; Ju R; Chen XL; Shao H; Zheng YX; Dai YF
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):418-22. PubMed ID: 27141897
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the relationship between the changes of lung function and serum proinflammatory cytokines in workers occupationally exposed to toluene diisocyanate].
Niu Y; Miao PP; Wang JC; Meng T; Jia Q; Shen ML; Bin P; Duan HW; Shao H; Dai YF
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):673-678. PubMed ID: 32842285
[No Abstract] [Full Text] [Related]
3. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
Kong YJ; Sun WX; Zhang YM; Shi YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
[TBL] [Abstract][Full Text] [Related]
4. [Effect of occupational exposure to toluene diisocyanate on workers' health].
Ju R; Jia Q; Meng T; Wang C; Chen X; Niu Y; Meng X; Geng X; Ma Y; Jia Q; Miao P; Dai Y; Zheng Y; Shao H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2016 Jan; 34(1):23-6. PubMed ID: 27014811
[TBL] [Abstract][Full Text] [Related]
5. [Effect of toluene diisocyanate on lung function of workers].
Liu BF; Liu H; Zhang M; Zhao X; Yang DY; Ren J; Wang YR
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Nov; 31(11):844-5. PubMed ID: 24370296
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma.
Park HS; Kim HA; Jung JW; Kim YK; Lee SK; Kim SS; Nahm DH
Clin Exp Allergy; 2003 Jan; 33(1):113-8. PubMed ID: 12534559
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
8. [Effects of shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in acute exacerbated chronic obstructive pulmonary disease patients].
Wang TJ; Xie ZH; Zhao ZZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):191-4. PubMed ID: 22574591
[TBL] [Abstract][Full Text] [Related]
9. Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1.
Shen DD; Yang ZH; Huang J; Yang F; Lin ZW; Ou YF; Hu MH
Pharm Biol; 2019 Dec; 57(1):744-752. PubMed ID: 31679431
[No Abstract] [Full Text] [Related]
10. [Influence of N-acetylcysteine on the cytokines and matrix metalloproteinases in chronic obstructive pulmonary disease rat models].
Xu L; Cai BQ; Zhu YJ; Guo ZJ; Zhang H; Gu L; Xu XX
Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):595-9. PubMed ID: 15355665
[TBL] [Abstract][Full Text] [Related]
11. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Beeh KM; Beier J; Kornmann O; Buhl R
Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
[TBL] [Abstract][Full Text] [Related]
12. Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma.
Lee KS; Jin SM; Lee H; Lee YC
Clin Exp Allergy; 2004 Feb; 34(2):276-84. PubMed ID: 14987308
[TBL] [Abstract][Full Text] [Related]
13. An epidemiology study of lung function changes of toluene diisocyanate foam workers in the United Kingdom.
Clark RL; Bugler J; McDermott M; Hill ID; Allport DC; Chamberlain JD
Int Arch Occup Environ Health; 1998 May; 71(3):169-79. PubMed ID: 9591158
[TBL] [Abstract][Full Text] [Related]
14. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
[TBL] [Abstract][Full Text] [Related]
15. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
16. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
17. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
[TBL] [Abstract][Full Text] [Related]
18. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
19. Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remodelling.
Yu WC; Cong JP; Mi LY
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):361-367. PubMed ID: 30133616
[TBL] [Abstract][Full Text] [Related]
20. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
